The Art of Momo

[phunnibone]

Good news with SDVI:

http://alturl.com/7nqbs

Signature Devices Inc. Announces Gold Status for 24 Reader Rabbit® Titles in Six Languages

[phunnibone]

XTend Medical Corporation/MultiCorp International, Inc. Name Changeand Symbol Change Finalized

Aug 27, 2012 12:01:39 (ET)
SUN VALLEY, CA, Aug 27, 2012 (MARKETWIRE via COMTEX) -- MultiCorp International, Inc. /XTend Medical Corporation (pinksheets:XMDC), has finalized the name/symbol change with FINRA and the company will begin trading under the symbol MCIC effective on August 28, 2012.

The company also announced that the CEO and President of the company have converted their holdings of common shares back into preferred shares, thus lowering the outstanding shares by 400 million.

The company released the following statement: "The Company has finalized the name change and symbol change only with FINRA and the new symbol, MCIC, will become effective tomorrow, August 28, 2012. As FINRA had changed their policies regarding the process to complete these steps, this action took longer than first perceived. This will better reflect our new direction for the company. In addition, Mr. Friedman and Mr. Lisenby decided to convert 400 million common shares back to 40 million preferred shares. This will lower the company's outstanding common shares by 400 million," stated Mr. Paul D. Lisenby, CEO of MultiCorp International, Inc. Mr. Lisenby further states, "The Company will continue to aggressively pursue acquisitions that have potential to grow revenues and profits for MultiCorp and their shareholders. If the acquisition targets meet the company's criteria of management and business sector for growth, then MultiCorp will move forward with our due diligence process and close these accordingly."

This is a big deal, IMO.

[phunnibone]

Thursday , August 02, 2012 12:15ET

MANCHESTER, N.H., Aug. 2, 2012 /PRNewswire/ -- QED Connect, Inc. ("QED Connect") (OTC Pink Sheets: QEDN) today announced that it has entered into letters of intent (LOI) to acquire 100% of Terra Resources and Kuma Oil, both oil and gas companies, and Kyrzyg Alumina, an aluminum mining company.

Terra, through its subsidiary company NV Alliance, has oil and gas rights in the Republic of Kalmykia, a subject of the Russian Federation. Kuma Oil, a Russian company, owns oil and gas rights in the Russian territory of Perm Krai. The companies currently operate and own multiple wells and perform drilling, pumping, and transportation through the commercial distribution system. Terra and Kuma have combined proven oil reserves of 570 million barrels with an estimated value of approximately $2 billion. The companies also have future exploration rights in their respective territories.

Kyrzyg Alumina owns mines containing the raw material necessary to produce alumina (aluminum oxide). After extracting the compounds, the alumina is subjected to electrolysis in a solution of cryolite, which is composed of sodium aluminum fluoride. Five hundred metric tons of alumina can yield approximately $500 million in revenue. Aluminum is one of the most ubiquitous manufacturing materials of the industrialized era and this commonplace metal has tremendous potential as an ecological fuel source.

Victor Prediger, CEO of Magna Resources Corp., the holding company for Terra and Kuma Oil, stated, "We have been looking for a partner to help us obtain working capital and provide a presence in the US. QED Connect is well positioned to support our business plan and our goals to maximize the potential of Terra and Kuma Oil. We are very excited to be working with QED Connect to move these projects to the next level."

Michael Roth, CEO of Kyrzyg Alumina commented, "Aluminum represents the second most popular commodity in the world. Companies with reserves are in a good position to capitalize on this growing demand. We have been seeking a partner to help obtain the necessary working capital to begin our mining operations and we believe that QED Connect can provide the resources required to support our operations."

Tom Makmann, President and CEO of QED Connect commented, "Terra and Kuma Oil offer QED Connect the opportunity to participate in the oil and gas industry. We have been working to expand into other industries and are excited about the opportunity these companies bring to QED Connect. A typical oil well in Kalmykia produces up to 1,000 barrels a day, which can have the potential of contributing greatly to QED Connect's financial performance." Mr. Makmann added, "With aluminum reserves in limited supply, we are very enthusiastic about the potential that Kyrzyg Alumina can bring to QED Connect, thus increasing shareholder value."

The definitive agreements are expected to close within the next 75 days pending due diligence and approval of any regulatory agencies and each company's respective board of directors.

QED Connect is continuing its strategy of acquisitions, investments, and strategic business alliances and expects to finalize its current investments during the fourth quarter of 2012. We are focusing on businesses that are producing revenue and are seeking capital and/or management assistance to execute their business plan. QED Connect looks for companies that are synergistic and/or offer the opportunity to develop a business in a market that has growth potential.

QED Connect's current investments and joint ventures include:

-- Sofame Energy, Inc., a joint venture with Sofame Technologies, has sold
the custom-designed "Hybrid Percomtherm®" boiler which recovers boiler
flue gas heat from existing boilers and recycles the heat, thereby
leading to overall energy efficiency. The company experienced an
increase in order activity receiving six contracts for a total value of
$1.94 million. The orders were from a food processor, a hospital, a
yeast producer and a College in Colorado.
-- Nazz Productions, a movie producer. Nazz's feature film, "Good Day For
It", won Favorite Feature at the 2011 Sonoma International Film Festival
and opened theatrically in Los Angeles in July and available on DVD and
video on demand.
-- StockProfile.com, a customized platform showcasing emerging growth
stocks to independent investors. In June 2011, QED Connect purchased
100% of the assets of StockProfile.com.

As a result of its continued success in the mergers and acquisitions arena, QED Connect is considering becoming a "business development company" as defined under the Investment Company Act of 1940.
--------------------

[phunnibone]

QEDN has news: http://ih.advfn.com/p.php?pid=nmona&article=53692404

I've had this stock for years, hoping for news and some movement and a possible home run. Take a look.

[gorbec1]

xmdc released their Attorney Letter with Respect to Current Information. 6/5/2012 06:18 PM

[phunnibone]

Thanks, I prefer the fantasy women. Paul Lisenby knows what he is doing, and I think his concept is solid. He only acquires companies that are making a profit and those companies are expanding. So far, so good!

And I think his main business will be medical.

[AUminer]

You Post some Amazingly Beautiful Posts. I'll be taking a Look at the XMDC.

[phunnibone]

XMDC has two companies, now, both expanding. I think the biggest thing will be medical. I also see CEO Paul Lisenby as uplisting in the near future. XMDC will no longer be XMDC -- it'll be something else. The corporation already has a new name -- MultiCorp International, Inc./XTend Medical Corporation -- but we'll see what the ticker will be in the near future.

[phunnibone]

More to come!





XTend Medical Corporation (XMDC) Begins Process to Change Name to MultiCorp International, Inc.

[gorbec1]

dont forget they also have been getting finacials out its like one atty letter away from uplisting from what i hear

[phunnibone]

XMDC has gotten it's first company; more to come. Name change in progress.
Uplist anticipated. Value of the stock will go up as time goes by.

[Choi]

Ohhhh mick, please tell me that's so!

[mick]

red x in this ibox...maybe my pc no good.

[Choi]

[phunnibone]

It seems I'm having a harder time than I thought, finding the stuff I thought.



My thinking about XMDC is that since Paul Lisenby has not posted news, yet, some are showing their ambivalence with their PPS. I'm not worried.

[phunnibone]

XMDC is new (was XMDCQ). CEO got tired of his partner and went forward with BK and will have a new partner (two be announced.) Stay tuned!

[EZmoneyED]

GSX momentum building watch for resistance to break at .27 then off to the races. News pending on newly spudded oil wells.

[Planopenny]

FDMF on watch tommorow

[QuickDraw007]

NEIK YIPPPEEEEEEEEEE !! More To Come

Ceo Says Private Placement Done In Days!

[EZmoneyED]

LUXD fireworks will begin soon imo.

[bewenched]

FBCD Breakout

[EZmoneyED]

APDN huge bid support something brewing? Current .055

[EZmoneyED]

CMEY radar is beeping folks you better pay attention. When it runs you will be chasing. imo

[EZmoneyED]

Like I said. $$$$$

[EZmoneyED]

LUXD reverse merger in the works according to last filing and chart is poised for take off:) Going to be a fun one imo.

[phunnibone]

Had to go through some legal stuff having to do with control of the patent. CEO Paul Lisenby prevailed. Now all they have to do is sign the paperwork and then Paul will get rid of the Q, and we are in business, ladies and gentlemen.

Down the road, Paul will clear up this -- -- and get this cleared up -- and then uplist.

In the mean time, they get manufacturing going, followed by sales. And by sales, we mean global sales. I think first, they'll be focusing on race horses, because there's no need for FDA approval AND because they are high profile. Everybody in horse racing will want the Harp. Every single one. It will create a lot of interest. Then we'll move on to other critters, Maybe zoos and animal hospitals. In the meantime, we expect FDA approval to be relatively fast do to the fact that there is no radiation, dyes, or needles. It's strictly hands off, and if there is any inflammation, they'll find it.

With patents in 82 countries, then that just hammers the point that this WILL be global. Some countries have already expressed an interest in the Harp.

If I can't interest anybody in this then nobody will be. LOL! Xtend will probably make a few million the first year as manufacturing gears up. Maybe more than that.

[$b_rich$]

Have a great 3 day weekend all!

[phunnibone]

XMDCQ / Xtend Medical

We have news! The addendum that Paul Lisenby and Dr Lee have been working on is done. It's just a matter of time before Paul receives the hard copy. He'll sign it and give us the PR we've been waiting for.

Great news!!! Stock will get a very nice boost when it that PR comes. May get a bump before it gets here.

Saddle up!

[EZmoneyED]

VMSYQ called at .008 todays high was .0175 YEP!

[phunnibone]

Xtend Medical
Looking nice, today,
but waiting for news.

[MasterBidder]

VMSYQ - With a chart like this how can you not have this on watch!?



Closed HOD, RSI heading for Power Zone, MACD shows lots of room to climb, Accum going up, best chart set up I have seen in AGES! JUICY JUICY JUICY...

Looks like the market is confident that VMSYQ is going to emerge from BK with commons intact...then BOOOOOOOOOM LOOKOUT!

Gotta love stocks like this one!

GLTA SEE U IN PENNYLAND!

KIG

[EZmoneyED]

APDN also on watch for a big move imo. Currently in the .07s New board members being appointed who have some very nice credentials. You have to follow the bread crumbs folks to be in ahead of the crowd.

[EZmoneyED]

VMSYQ momo building there on watch for tomorrow:)

[EZmoneyED]

TVCE rumors starting and who knows they might be true:)

[phunnibone]

XMDCQ is in consolidation for a couple of days, according to Matt and hischart, then it'll be moving:

[EZmoneyED]

MWWC keep on close watch. When the fireworks start dont hesitate or you will get left in the dust.

[phunnibone]

Ladies and Gents, lets take a look at Xtend Medical



Not to mention news on Pacer..

Things are happening as fast as they can make'm happen.

BTW, this is Matt's chart, and it's to his credit.

[Choi]

GTGP, see the action before it happens.

[$b_rich$]

Good morning all!

[phunnibone]

Movement with few shares bought. With more people getting off the sidelines, it could get interesting, fast.

[phunnibone]

XMDCQ

A reminder of past notes about the BioHarp having to do with market potential:

"As the company moves closer to completing the merger with BioHarp Korea, the management feels it is vital for our shareholders to understand the market potential and the revenue model of the BioHarp device. The BioHarp unit market potential stretches globally. There has been interest from several health departments globally to deploy the BioHarp to outlying village areas and major metropolitan healthcare clinics to utilize the BioHarp as an effective tool for pre-diagnosis on regular physical appointments. Since the BioHarp can travel anywhere with a laptop, the ability for these countries to deploy the unit to hard to get geographical areas allows these countries to scan the patient and choose the correct follow-up procedures that can save these countries millions of dollars in healthcare costs. These countries will use the five sensor unit and the software will be integrated into their respective national healthcare databases. "In addition to the human markets, the BioHarp will be marketed to the pet and equine industries. The management at XTend has made several contacts with the veterinary market to utilize the BioHarp to scan dogs, cats, and other pets in order to discover potential harmful conditions that can be treated through nutrition and medications. The ability for the veterinarian to market this as an added service allows them to create an additional revenue stream as well as giving pet owners the ability to monitor their pet's health and hopefully alleviate costly procedures. The equine industry itself can be very lucrative for the company in the future. The management at XTend has several thoroughbred trainers and owners they have spoken with about utilizing the BioHarp as part of a daily routine for racehorses to insure their training and subsequent earnings potential is not compromised. As the BioHarp unit can be deployed to the stables, part of their post exercise routine would be for the trainer or vet to scan the horse upon completion of their workout or race and determine if there is any underlying inflammation that can lead to being sidelined, thereby eliminating the ability to earn money racing. This market alone is global in nature as there are literally hundreds of racetracks with thousands of horses, each representing a significant investment to their owners. The yearling sales at places like Keenland, wherein owners plunk down millions to own a potential Triple Crown winner, would benefit by having a BioHarp scanner available in order to scan potential champions to insure the fitness of the horse and to detect potential problems that could arise in the future. These scans would be done with the one sensor unit and would probably be sold and managed by our internal medical team at BioHarp UNI US. The potential trainers and owners would contract with us to scan the animals regularly; generating daily, weekly, and/or a monthly maintenance fee schedule for the company. "The revenue model for the BioHarp comes from both the hardware and software sales. The single sensor unit will sell for $5,000 US dollars and the five sensor unit will be $30,000. The software will be sold on a license agreement wherein BioHarp UNI US will charge $19.99 per month per patient license, thereby creating a continued revenue stream once the unit hardware is sold. Naturally, if we have groups that are purchasing thousands of units, we will have a discount structure to these monthly fees. With the patient potential in the millions, our revenue model will be very strong and consistent for years to come. "Lastly I would like to touch on our corporate structure and how we feel the share structure will be beneficial for all current and future shareholders of the company. We strongly feel that our Authorized shares at this time are sufficient to handle our merger and capital raise needs. We feel it would be disadvantageous to do any sort of reverse split due to the potential sales of the BioHarp unit in the coming years. If we realize our sales and marketing goals and hit our projected revenues based on the current inquiries we've received, the company's market cap will be substantial," stated Mr. Paul D. Lisenby, CEO of XTend Medical.

-----------

The potential for this device to change the way patient diagnostics are currently being done is tremendous. The BioHarp is a non-invasive scanning device that can be used by a trained professional to scan the body to find cellular inflammation, utilizing nano bio-sensors. In layman's terms, whenever there is inflammation in the body on a cellular level, the potential for health issues can result. The BioHarp is a patent protected device that doesn't require any dyes or foreign fluid to be introduced into the body to attain a reading, or better yet, gives the patient results based on their individual body baseline. In short, this device can be used as an early diagnostic device by any country, healthcare company, managed care company, military, and in almost any other situation where an early diagnosis can assist in saving lives and lowering healthcare costs. The work done by our management team with the principles at BioHarp, Korea, has taken us over two years to get to this point in our relationship wherein we feel comfortable merging with their organization and they feel the same way with us. Our hard work over the past three years in dealing with managed care companies, physician groups, and other healthcare organizations will prove to be most beneficial in securing future contracts for the BioHarp once the merger is complete. BioHarp, Korea has spent the last 14 years working on bringing the BioHarp unit to its current level of perfection and by combining our resources we gain solid management, premiere manufacturing, and the potential for a global company that will make BioHarp the most used medical device in early diagnosis. There was a press release in February 2008, issued by Hathaway Corporation, announcing a joint venture with UNI Bio-Tech for the BioHarp device. As I was with the company at that time acting as the interim CEO, I knew the value of BioHarp. However, since the Board of Directors of Hathaway decided to change their business model to become FutureWorld Energy and focus their efforts on the renewable energy sector, the joint venture never took place and the deal was cancelled in April of 2008. My work with Hathaway has since stopped and for the last 18 months my sole responsibility has been to ensure XTend Medical brings value to our shareholders and puts itself in a position to capitalize on opportunities to grow the company. Through this merger, the company will become a global leader in the healthcare sector and it will be up to all of us here at XTend Medical and BioHarp, Korea to ensure that this happens. Since the announcement of this merger, we have been working hard with Pink Sheets to become fully compliant with their reporting requirements. We should have this accomplished by week's end and hopefully have the Stop Sign removed from our company's profile. Our goal is to move up to a greater exchange due to the potential sales that we anticipate the BioHarp will be doing globally very soon. We are working with our accountant and legal teams to ensure that we have everything in order so the migration to a higher exchange can be accomplished at the proper time. Any changes we've recently made to the corporate structure are to effectuate this merger and any and all shares issued for this merger are subject to Rule 144 Restrictions. As we update Pink Sheets, the information will be there for all shareholders to review. We are in the process of updating our site and will share additional information about our progress in future press releases. In closing, I would like to thank all of our loyal shareholders for their dedication and for potential future shareholders; this company will be strong and have a very bright future for many years to come."

[phunnibone]

XMDCQ

As one guy put it:

1100% increase in PPS in the last few weeks.
Holding strong at near the high.
Confirmation from the office that a deal was reached.
Parties talking every two days.


There is a lot more on the way. Get your tickets, so you can leave everybody else behind.

[$b_rich$]

GLGT... some nice updates and DD coming off the bottom

AS 950M
OS 869,238,933


waiting on a call back for the float.


Heritage Transfer Agency

Transfer Agent
4 King Street West
Toronto, ONT, M5H 1B6
416-364-9509

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65606228

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65604871

website where I received an email from Mr Qian, Listed President of GLGT per Nev. SOS..Looks like they're updating it as well:

http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=RpUjOC1CZJi3p4ILS9oqNQ%253d%253d&nt7=0

[e-mail]
http://www.abgenom.com/index.html

[$b_rich$]

Good morning all!

[MIKAL]

I completely agree. IMO, CMEY will explode within the next six weeks. At this current time, it has been just over 4 months since CMEY first mentioned they had started working on the S-1 and I believe it is ready.

IMO, MMs appear to be walking this down trying to shake out loose hands one last time before the big run. The one thing MMs didnt want to happen appears to be happening, almost NO ONE IS SELLING. Longs are VERY strong here. Go CMEY!

[EZmoneyED]

Still calling CMEY tickets are cheap now but give it a little time Im thinking 10 bagger. Better pay attention folks you got to get in early to make the biggest gains. All my little ole opinion.

[Choi]

Hey, that's the way you gotta roll sometimes... Investments in penny is naturally stigmatized with a taboo coding... That's only if you believe that... I made some good cheese getting in on the action early... See the action before it happens! haha....

[EZmoneyED]

I usually am very early to the party with my picks so dont think its gonna blow up tomorrow but this will run in time.

[EZmoneyED]

DMPD getting some hits and way overdue for some news. Current .0019 target .008

[phunnibone]

XMDCQ -- possible Golden Cross +.

I'm not as conservative as some. I personally think this will happen sooner due to the gradual pressure being exerted. The more people buy in, the tighter stocks will be. And, with news, it will be a lot sooner.